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• Long	term	use of	pPB-HSA	requires a	sophisticated	formulation,	such








14d	releaseProtein X10 (μm) X50 (μm) X90 (μm)
pPB-HSA/HSA 6.56 24.74 50.22 83% 95%


















pPB-HSA	treated mice,	as	shown	by ELISA	and western	blot.



















































Protein level of HSA 
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Microspheres after subcutaneous administration
7	days	after	administration,	HSA	and pPB-HSA	were still
present	in	microspheres that were localized subcutaneously,	
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